These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 21181208

  • 1. Pathogenesis, diagnosis and management of hyperkalemia.
    Lehnhardt A, Kemper MJ.
    Pediatr Nephrol; 2011 Mar; 26(3):377-84. PubMed ID: 21181208
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potassium homeostasis and hyperkalemic syndromes.
    Clark BA, Brown RS.
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):573-91. PubMed ID: 8575410
    [Abstract] [Full Text] [Related]

  • 6. New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors.
    Tamargo J, Caballero R, Delpón E.
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):99-119. PubMed ID: 29372448
    [Abstract] [Full Text] [Related]

  • 7. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
    Parikh RV, Nash DM, Brimble KS, Markle-Reid M, Tan TC, McArthur E, Khoshniat-Rad F, Sood MM, Zheng S, Pravoverov L, Nesrallah GE, Garg AX, Go AS.
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME.
    J Am Heart Assoc; 2017 Jul 19; 6(7):. PubMed ID: 28724651
    [Abstract] [Full Text] [Related]

  • 10. Potassium homeostasis in chronic kidney disease.
    Palmer BF.
    Nephrol News Issues; 2016 Apr 19; 30(4):suppl 8-10, 12-3. PubMed ID: 27254899
    [Abstract] [Full Text] [Related]

  • 11. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
    McCullough PA, Beaver TM, Bennett-Guerrero E, Emmett M, Fonarow GC, Goyal A, Herzog CA, Kosiborod M, Palmer BF.
    Rev Cardiovasc Med; 2014 Apr 19; 15(1):11-23. PubMed ID: 24762462
    [Abstract] [Full Text] [Related]

  • 12. [Hyperkalemia - Pathophysiology, prognostic significance and treatment options].
    Gerhardt LMS, Angermann CE.
    Dtsch Med Wochenschr; 2019 Nov 19; 144(22):1576-1584. PubMed ID: 31658482
    [Abstract] [Full Text] [Related]

  • 13. Pseudohyperkalemia: Look before you treat.
    De Rosales AR, Siripala DS, Bodana S, Ahmed F, Kumbala DR.
    Saudi J Kidney Dis Transpl; 2017 Nov 19; 28(2):410-414. PubMed ID: 28352030
    [Abstract] [Full Text] [Related]

  • 14. Hyperkalemia: recognition and management of a critical electrolyte disturbance.
    Crawford AH.
    J Infus Nurs; 2014 Nov 19; 37(3):167-75. PubMed ID: 24694510
    [Abstract] [Full Text] [Related]

  • 15. Persistent hyperkalaemia.
    Xu B, Murray M.
    Aust Fam Physician; 2009 May 19; 38(5):307-9. PubMed ID: 19458800
    [Abstract] [Full Text] [Related]

  • 16. Excessive watermelon consumption causing hyperkalaemia and increased symptom burden of an end stage renal disease patient.
    Chan KY, Yap DY, Li CW, Cheng HW, Au HY.
    Nephrology (Carlton); 2016 Aug 19; 21(8):721. PubMed ID: 27436619
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.